Dengue Fever – Pipeline Review, H2 2019

“Global Markets Direct’s, ‘Dengue Fever – Pipeline Review, H2 2019’, provides an overview of the Dengue Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Dengue Fever, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Dengue Fever and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.”

Scope


– The report provides a snapshot of the global therapeutic landscape of Dengue Fever

– The report reviews pipeline therapeutics for Dengue Fever by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved Dengue Fever therapeutics and enlists all their major and minor projects

– The report assesses Dengue Fever therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news related to pipeline therapeutics for Dengue Fever”

Reasons to buy

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Dengue Fever

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Dengue Fever pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

“60 Degrees Pharmaceuticals LLC

Abhelix LLC

Abivax SA

Aluda Pharmaceuticals Inc

Avida Biotech SL

Biological Mimetics Inc

BioNet- Asia Co Ltd

Biotron Ltd

Chugai Pharmaceutical Co Ltd

Cidara Therapeutics Inc

Clayton Biotechnologies Inc

Codagenix Inc

Emergex Vaccines Ltd

Ennaid Therapeutics LLC

Etna Biotech Srl

Excivion Ltd

F4 Pharma GmbH

GlaxoSmithKline Plc

Globavir Biosciences Inc

Greffex Inc

Hawaii Biotech Inc

HSRx Group

Humabs BioMed SA

Immunomodulation Inc

Immunotope Inc

Imutex Ltd

Indian Immunologicals Ltd

Inovio Pharmaceuticals Inc

ISLA Pharmaceuticals Inc

Johnson & Johnson

Kineta Inc

KM Biologics Co Ltd

Macrophage Therapeutics Inc

Medigen Inc

Najit Technologies Inc

Panacea Biotec Ltd

Plex Pharmaceuticals Inc

ProtInhi BV

Riboscience LLC

Seagull Labs (I) Pvt Ltd

Serum Institute of India Ltd

Shionogi & Co Ltd

Sun Pharma Advanced Research Company Ltd

Takeda Pharmaceutical Co Ltd

TechnoVax Inc

Virocovax

Visterra Inc

VLP Therapeutics LLC

Xenothera SAS”

Table of Contents

Table of Contents

Table of Contents 2

Introduction 5

Dengue Fever Overview 6

Dengue Fever Therapeutics Development 7

Dengue Fever Therapeutics Assessment 18

Dengue Fever Companies Involved in Therapeutics Development 26

Dengue Fever Drug Profiles 38

Dengue Fever Dormant Projects 132

Dengue Fever Discontinued Products 137

Dengue Fever Product Development Milestones 138

Appendix 149

List of Tables

“List of Tables

Number of Products under Development for Dengue Fever, H2 2019

Number of Products under Development by Companies, H2 2019

Number of Products under Development by Companies, H2 2019 (Contd..1), H2 2019

Number of Products under Development by Universities/Institutes, H2 2019

Products under Development by Companies, H2 2019

Products under Development by Companies, H2 2019 (Contd..1), H2 2019

Products under Development by Companies, H2 2019 (Contd..2), H2 2019

Products under Development by Universities/Institutes, H2 2019

Products under Development by Universities/Institutes, H2 2019 (Contd..1), H2 2019

Number of Products by Stage and Target, H2 2019

Number of Products by Stage and Mechanism of Action, H2 2019

Number of Products by Stage and Route of Administration, H2 2019

Number of Products by Stage and Molecule Type, H2 2019

Dengue Fever – Pipeline by 60 Degrees Pharmaceuticals LLC, H2 2019

Dengue Fever – Pipeline by Abhelix LLC, H2 2019

Dengue Fever – Pipeline by Abivax SA, H2 2019

Dengue Fever – Pipeline by Aluda Pharmaceuticals Inc, H2 2019

Dengue Fever – Pipeline by Avida Biotech SL, H2 2019

Dengue Fever – Pipeline by Biological Mimetics Inc, H2 2019

Dengue Fever – Pipeline by BioNet- Asia Co Ltd, H2 2019

Dengue Fever – Pipeline by Biotron Ltd, H2 2019

Dengue Fever – Pipeline by Chugai Pharmaceutical Co Ltd, H2 2019

Dengue Fever – Pipeline by Cidara Therapeutics Inc, H2 2019

Dengue Fever – Pipeline by Clayton Biotechnologies Inc, H2 2019

Dengue Fever – Pipeline by Codagenix Inc, H2 2019

Dengue Fever – Pipeline by Emergex Vaccines Ltd, H2 2019

Dengue Fever – Pipeline by Ennaid Therapeutics LLC, H2 2019

Dengue Fever – Pipeline by Etna Biotech Srl, H2 2019

Dengue Fever – Pipeline by Excivion Ltd, H2 2019

Dengue Fever – Pipeline by F4 Pharma GmbH, H2 2019

Dengue Fever – Pipeline by GlaxoSmithKline Plc, H2 2019

Dengue Fever – Pipeline by Globavir Biosciences Inc, H2 2019

Dengue Fever – Pipeline by Greffex Inc, H2 2019

Dengue Fever – Pipeline by Hawaii Biotech Inc, H2 2019

Dengue Fever – Pipeline by HSRx Group, H2 2019

Dengue Fever – Pipeline by Humabs BioMed SA, H2 2019

Dengue Fever – Pipeline by Immunomodulation Inc, H2 2019

Dengue Fever – Pipeline by Immunotope Inc, H2 2019

Dengue Fever – Pipeline by Imutex Ltd, H2 2019

Dengue Fever – Pipeline by Indian Immunologicals Ltd, H2 2019

Dengue Fever – Pipeline by Inovio Pharmaceuticals Inc, H2 2019

Dengue Fever – Pipeline by ISLA Pharmaceuticals Inc, H2 2019

Dengue Fever – Pipeline by Johnson & Johnson, H2 2019

Dengue Fever – Pipeline by Kineta Inc, H2 2019

Dengue Fever – Pipeline by KM Biologics Co Ltd, H2 2019

Dengue Fever – Pipeline by Macrophage Therapeutics Inc, H2 2019

Dengue Fever – Pipeline by Medigen Inc, H2 2019

Dengue Fever – Pipeline by Najit Technologies Inc, H2 2019

Dengue Fever – Pipeline by Panacea Biotec Ltd, H2 2019

Dengue Fever – Pipeline by Plex Pharmaceuticals Inc, H2 2019

Dengue Fever – Pipeline by ProtInhi BV, H2 2019

Dengue Fever – Pipeline by Riboscience LLC, H2 2019

Dengue Fever – Pipeline by Seagull Labs (I) Pvt Ltd, H2 2019

Dengue Fever – Pipeline by Serum Institute of India Ltd, H2 2019

Dengue Fever – Pipeline by Shionogi & Co Ltd, H2 2019

Dengue Fever – Pipeline by Sun Pharma Advanced Research Company Ltd, H2 2019

Dengue Fever – Pipeline by Takeda Pharmaceutical Co Ltd, H2 2019

Dengue Fever – Pipeline by TechnoVax Inc, H2 2019

Dengue Fever – Pipeline by Virocovax, H2 2019

Dengue Fever – Pipeline by Visterra Inc, H2 2019

Dengue Fever – Pipeline by VLP Therapeutics LLC, H2 2019

Dengue Fever – Pipeline by Xenothera SAS, H2 2019

Dengue Fever – Dormant Projects, H2 2019

Dengue Fever – Dormant Projects, H2 2019 (Contd..1), H2 2019

Dengue Fever – Dormant Projects, H2 2019 (Contd..2), H2 2019

Dengue Fever – Dormant Projects, H2 2019 (Contd..3), H2 2019

Dengue Fever – Dormant Projects, H2 2019 (Contd..4), H2 2019

Dengue Fever – Dormant Projects, H2 2019 (Contd..5), H2 2019

Dengue Fever – Discontinued Products, H2 2019”

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports